SEVEN EIGHT CAPITAL, LP - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 288 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEVEN EIGHT CAPITAL, LP ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q4 2022$180,648
-12.7%
11,580
-21.6%
0.05%
-43.4%
Q2 2022$207,000
+4.5%
14,772
+6.7%
0.08%
+219.2%
Q1 2022$198,000
-34.0%
13,850
-37.1%
0.03%
-51.9%
Q4 2021$300,000
-85.7%
22,019
-82.8%
0.05%
-73.3%
Q3 2021$2,095,000
+52.4%
127,875
+56.6%
0.20%
+4.7%
Q2 2021$1,375,000
+329.7%
81,675
+358.3%
0.19%
-17.5%
Q2 2020$320,000
+1.3%
17,820
-14.3%
0.23%
+188.9%
Q1 2020$316,000
+17.0%
20,800
+52.1%
0.08%
+478.6%
Q4 2019$270,000
-61.4%
13,674
-66.4%
0.01%
-62.2%
Q3 2019$700,000
+293.3%
40,674
+303.8%
0.04%
+311.1%
Q2 2019$178,00010,0740.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2021
NameSharesValueWeighting ↓
Bartlett & Co. LLC 20,781$2960.01%
Valued Wealth Advisors LLC 231$3,5740.00%
BALDWIN BROTHERS LLC/MA 2,035$29,0390.00%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders